|
|
全身免疫炎症指数在呼吸系统疾病中的研究进展
|
Abstract:
炎症与呼吸系统疾病密切相关。全身免疫炎症指数(Systemic Immune-Inflammation Index, SII)是一种新型的综合性炎症指标，基于血小板、中性粒细胞及淋巴细胞的计数，能较为全面地反映机体的免疫炎症状态，且该指标为非侵入性、易获取、成本低，在恶性肿瘤及炎症相关性疾病的预后方面具有可靠的参考价值。本文就SII在呼吸系统疾病发生发展预测价值的最新进展予以综述。
Inflammation is closely related to respiratory diseases. Systemic immune inflammation index (SII) is a new type of comprehensive inflammatory index, which can comprehensively reflect the immune inflammatory state of the body based on the count of platelets, neutrophils and lymphocytes, and it is non-invasive, easy to obtain and low cost. It has reliable reference value in the prognosis of malignant tumors and inflammation-related diseases. This article reviews the latest progress in the predictive value of SII in the occurrence and development of respiratory diseases.
| [1] | Hurgobin, B., De Jong, E. and Bosco, A. (2018) Insights into Respiratory Disease through Bioinformatics. Respirology, 23, 1117-1126. https://doi.org/10.1111/resp.13401 |
| [2] | García-Río, F., Alcázar-Navarrete, B., Castillo-Villegas, D., et al. (2022) Biological Biomarkers in Respiratory Diseases. Archivos de Bronconeumología, 58, 323-333. https://doi.org/10.1016/j.arbres.2022.01.003 |
| [3] | Guo, D., Zhang, J., Jing, W., et al. (2018) Prognostic Value of Systemic Immune-Inflammation Index in Patients with Advanced Non-Small-Cell Lung Cancer. Future Oncology, 14, 2643-2650. https://doi.org/10.2217/fon-2018-0285 |
| [4] | Hu, B., Yang, X.-R., Xu, Y., et al. (2014) Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. Clinical Cancer Research, 20, 6212-6222. https://doi.org/10.1158/1078-0432.CCR-14-0442 |
| [5] | Siegel, R.L., Miller, K.D. and Jemal, A. (2019) Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34. https://doi.org/10.3322/caac.21551 |
| [6] | Barta, J.A., Powell, C.A. and Wisnivesky, J.P. (2019) Global Epidemiology of Lung Cancer. Annals of Global Health, 85, 8. https://doi.org/10.5334/aogh.2419 |
| [7] | Torre, L.A., Siegel, R.L. and Jemal, A. (2016) Lung Cancer Statistics. In: Ahmad, A. and Gadgeel, S., Eds., Lung Cancer and Personalized Medicine, Springer, Berlin, 1-19. https://doi.org/10.1007/978-3-319-24223-1_1 |
| [8] | Chen, W., Sun, K., Zheng, R., et al. (2018) Cancer Incidence and Mortality in China, 2014. Chinese Journal of Cancer Research, 30, 1-12. https://doi.org/10.21147/j.issn.1000-9604.2018.01.01 |
| [9] | Bade, B.C. and Dela Cruz, C.S. (2020) Lung Cancer 2020. Clinics in Chest Medicine, 41, 1-24. https://doi.org/10.1016/j.ccm.2019.10.001 |
| [10] | Mantovani, A., Allavena, P., Sica, A., et al. (2008) Cancer-Related Inflammation. Nature, 454, 436-444. https://doi.org/10.1038/nature07205 |
| [11] | Vidal, A.C., Howard, L.E., De Hoedt, A., et al. (2018) Neutrophil, Lymphocyte and Platelet Counts, and Risk of Prostate Cancer Outcomes in White and Black Men: Results from the SEARCH Database. Cancer Causes Control, 29, 581-588. https://doi.org/10.1007/s10552-018-1031-2 |
| [12] | Leblanc, R., Houssin, A. and Peyruchaud, O. (2018) Platelets, Autotaxin and Lysophosphatidic Acid Signalling: Win-Win Factors for Cancer Metastasis. British Journal of Pharmacology, 175, 3100-3110. https://doi.org/10.1111/bph.14362 |
| [13] | Zhang, Y., Chen, B., Wang, L., et al. (2019) Systemic Immune-Inflammation Index Is a Promising Noninvasive Marker to Predict Survival of Lung Cancer. Medicine, 98, e13788. https://doi.org/10.1097/MD.0000000000013788 |
| [14] | Amiri, A., Pourhanifeh, M.H., Mirzaei, H.R., et al. (2021) Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications. Current Medicinal Chemistry, 28, 308-328. https://doi.org/10.2174/0929867327666200204141952 |
| [15] | Osmani, L., Askin, F., Gabrielson, E., et al. (2018) Current WHO Guidelines and the Critical Role of Immunohistochemical Markers in the Subclassification of Non-Small Cell Lung Carcinoma (NSCLC): Moving from Targeted Therapy to Immunotherapy. Seminars in Cancer Biology, 52, 103-109. https://doi.org/10.1016/j.semcancer.2017.11.019 |
| [16] | Alexander, M., Kim, S.Y. and Cheng, H. (2020) Update 2020: Management of Non-Small Cell Lung Cancer. Lung, 198, 897-907. https://doi.org/10.1007/s00408-020-00407-5 |
| [17] | Chen, Y., Zhou, H., Yang, S., et al. (2021) Increased ABCC2 Expression Predicts Cisplatin Resistance in Non-Small Cell Lung Cancer. Cell Biochemistry and Function, 39, 277-286. https://doi.org/10.1002/cbf.3577 |
| [18] | Huang, W., Luo, J., Wen, J., et al. (2022) The Relationship between Systemic Immune Inflammatory Index and Prognosis of Patients with Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review. Frontiers in Surgery, 9, Article ID: 898304. https://doi.org/10.3389/fsurg.2022.898304 |
| [19] | Fu, F., Deng, C., Wen, Z., et al. (2021) Systemic Immune-Inflammation Index Is a Stage-Dependent Prognostic Factor in Patients with Operable Non-Small Cell Lung Cancer. Translational Lung Cancer Research, 10, 3144-3154. https://doi.org/10.21037/tlcr-21-267 |
| [20] | Yu, Y., Xu, S. and Cao, S. (2021) High Systemic Immune-Inflammation Index Is a Predictor of Poor Prognosis in Patients with Nonsmall Cell Lung Cancer and Bone Metastasis. Journal of Cancer Research and Therapeutics, 17, 1636-1642. https://doi.org/10.4103/jcrt.jcrt_176_21 |
| [21] | Liu, J., Li, S., Zhang, S., et al. (2019) Systemic Immune-Inflammation Index, Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio Can Predict Clinical Outcomes in Patients with Metastatic Non-Small-Cell Lung Cancer Treated with Nivolumab. Journal of Clinical Laboratory Analysis, 33, e22964. https://doi.org/10.1002/jcla.22964 |
| [22] | Putzu, C., Cortinovis, D.L., Colonese, F., et al. (2018) Blood Cell Count Indexes as Predictors of Outcomes in Advanced Non-Small-Cell Lung Cancer Patients Treated with Nivolumab. Cancer Immunology. Immunotherapy, 67, 1349-1353. https://doi.org/10.1007/s00262-018-2182-4 |
| [23] | Wang, Q., Tan, X., Deng, G., et al. (2022) Dynamic Changes in the Systemic Immune-Inflammation Index Predict the Prognosis of EGFR-Mutant Lung Adenocarcinoma Patients Receiving Brain Metastasis Radiotherapy. BMC Pulmonary Medicine, 22, Article No. 75. https://doi.org/10.1186/s12890-022-01866-7 |
| [24] | Remon, J., Aldea, M., Besse, B., et al. (2021) Small Cell Lung Cancer: A Slightly Less Orphan Disease after Immunotherapy. Annals of Oncology, 32, 698-709. https://doi.org/10.1016/j.annonc.2021.02.025 |
| [25] | Zhou, Y., Dai, M. and Zhang, Z. (2022) Prognostic Significance of the Systemic Immune-Inflammation Index (SII) in Patients with Small Cell Lung Cancer: A Meta-Analysis. Frontiers in Oncology, 12, Article ID: 814727. https://doi.org/10.3389/fonc.2022.814727 |
| [26] | López-Campos, J.L., Tan, W. and Soriano, J.B. (2015) Global Burden of COPD. Respirology, 21, 14-23. https://doi.org/10.1111/resp.12660 |
| [27] | Benjamin, J.T., Plosa, E.J., Sucre, J.M.S., et al. (2021) Neutrophilic Inflammation during Lung Development Disrupts Elastin Assembly and Predisposes Adult Mice to COPD. Journal of Clinical Investigation, 131, e139481. https://doi.org/10.1172/JCI139481 |
| [28] | Van Eeden Stephan, F. and Hogg, J.C. (2020) Immune-Modulation in Chronic Obstructive Pulmonary Disease: Current Concepts and Future Strategies. Respiration, 99, 550-565. https://doi.org/10.1159/000502261 |
| [29] | Ye, C., Yuan, L., Wu, K., et al. (2023) Association between Systemic Immune-Inflammation Index and Chronic Obstructive Pulmonary Disease: A Population-Based Study. BMC Pulmonary Medicine, 23, Article No. 295. https://doi.org/10.1186/s12890-023-02583-5 |
| [30] | Liu, X., Ge, H., Feng, X., et al. (2020) The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease. Frontiers in Medicine, 7, Article ID: 572435. https://doi.org/10.3389/fmed.2020.572435 |
| [31] | 左皓环, 刘雅琼, 郑云, 等. SIRI、SII对慢性阻塞性肺疾病急性加重期的诊断价值[J]. 临床肺科杂志, 2024, 29(1): 35-39. |
| [32] | Benz, E., Wijnant, S.R.A., Trajanoska, K., et al. (2022) Sarcopenia, Systemic Immune-Inflammation Index and All-Cause Mortality in Middle-Aged and Older People with COPD and Asthma: A Population-Based Study. ERJ Open Research, 8, Article ID: 00628-2021. https://doi.org/10.1183/23120541.00628-2021 |
| [33] | Mims, J.W. (2015) Asthma: Definitions and Pathophysiology. International Forum of Allergy & Rhinology, 5, S2-S6. https://doi.org/10.1002/alr.21609 |
| [34] | Szefler, S.J., Wenzel, S., Brown, R., et al. (2012) Asthma Outcomes: Biomarkers. Journal of Allergy and Clinical Immunology, 129, S9-S23. https://doi.org/10.1016/j.jaci.2011.12.979 |
| [35] | Ke, J., Qiu, F., Fan, W., et al. (2023) Associations of Complete Blood Cell Count-Derived Inflammatory Biomarkers with Asthma and Mortality in Adults: A Population-Based Study. Frontiers in Immunology, 14, Article ID: 1205687. https://doi.org/10.3389/fimmu.2023.1205687 |
| [36] | Erdogan, T. (2020) Role of Systemic Immune-Inflammation Index in Asthma and NSAID-Exacerbated Respiratory Disease. The Clinical Respiratory Journal, 15, 400-405. https://doi.org/10.1111/crj.13314 |
| [37] | Lanks, C.W., Musani, A.I. and Hsia, D.W. (2019) Community-Acquired Pneumonia and Hospital-Acquired Pneumonia. Medical Clinics of North America, 103, 487-501. https://doi.org/10.1016/j.mcna.2018.12.008 |
| [38] | Long, B., Long, D. and Koyfman, A. (2017) Emergency Medicine Evaluation of Community-Acquired Pneumonia: History, Examination, Imaging and Laboratory Assessment, and Risk Scores. Journal of Emergency Medicine, 53, 642-652. https://doi.org/10.1016/j.jemermed.2017.05.035 |
| [39] | Acar, E., Gokcen, H., Demir, A., et al. (2021) Comparison of Inflammation Markers with Prediction Scores in Patients with Community-Acquired Pneumonia. Bratislava Medical Journal, 122, 418-423. https://doi.org/10.4149/BLL_2021_069 |
| [40] | Cui, Z., Kuang, S., Yang, X., et al. (2023) Predictive Value of the Systemic Immune Inflammation (SII) Index for Stroke-Associated Pneumonia. Brain and Behavior, 13, E3302. https://doi.org/10.1002/brb3.3302 |
| [41] | Jiang, R., Li, P., Shen, W., et al. (2023) The Predictive Value of the Preoperative Systemic Immune-Inflammation Index in the Occurrence of Postoperative Pneumonia in Non-Small Cell Lung Cancer: A Retrospective Study Based on 1486 Cases. Thoracic Cancer, 14, 30-35. https://doi.org/10.1111/1759-7714.14691 |
| [42] | 闵娟, 郝立坤, 武智强, 等. 患者入院时血清AFR、SII及PCT水平对老年重症肺炎预后不良的预测效能[J]. 山东医药, 2023, 63(21): 57-60. |
| [43] | Karaaslan, T. and Karaaslan, E. (2022) Predictive Value of Systemic Immune-Inflammation Index in Determining Mortality in COVID-19 Patients. Journal of Critical Care Medicine (Universitatea De Medicina Si Farmacie Din Targu-Mures), 8, 156-164. https://doi.org/10.2478/jccm-2022-0013 |
| [44] | Haryati, H., Wicaksono, B. and Syahadatina, M. (2023) Complete Blood Count Derived Inflammation Indexes Predict Outcome in COVID-19 Patients: A Study in Indonesia. Journal of Infection in Developing Countries, 17, 319-326. https://doi.org/10.3855/jidc.16527 |
| [45] | Yuan, H., Tian, J. and Wen, L. (2024) Meta-Analysis of the Systemic Immune-Inflammatory Index and In-Hospital Mortality of COVID-19 Patients. Heliyon, 10, e23441. https://doi.org/10.1016/j.heliyon.2023.e23441 |
| [46] | Karimi, A., Shobeiri, P., Kulasinghe, A., et al. (2021) Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis. Frontiers in Immunology, 12, Article ID: 741061. https://doi.org/10.3389/fimmu.2021.741061 |
| [47] | Rahmati, M., Koyanagi, A., Banitalebi, E., et al. (2022) The Effect of SARS-CoV-2 Infection on Cardiac Function in Post-COVID-19 Survivors: A Systematic Review and Meta-Analysis. Journal of Medical Virology, 95, e28325. https://doi.org/10.1002/jmv.28325 |
| [48] | Mahalaxmi, I., Kaavya, J., Mohana Devi, S., et al. (2020) COVID-19 and Olfactory Dysfunction: A Possible Associative Approach towards Neurodegenerative Diseases. Journal of Cellular Physiology, 236, 763-770. https://doi.org/10.1002/jcp.29937 |
| [49] | Wells, A.U. and Hirani, N. (2008) Interstitial Lung Disease Guideline. Thorax, 63, V1-V58. https://doi.org/10.1136/thx.2008.101691 |
| [50] | Fernández, F.E., Peris Sánchez, R., Sabater, C., et al. (2018) Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis. Medical Sciences (Basel), 6, Article No. 51. https://doi.org/10.3390/medsci6020051 |
| [51] | Motoc, N.S., Man, M.A., Urda, A.E.C., et al. (2019) Neutrophil-to-Lymphocyte Ratio and Platelets-to-Lymphocytes Ratio in Severe COPD Exacerbation: The Importance of Obstructive Sleep Apnea. European Respiratory Journal, 54, PA2582. https://doi.org/10.1183/13993003.congress-2019.PA2582 |
| [52] | Paliogiannis, P., Fois, A.G., Sotgia, S., et al. (2018) Neutrophil to Lymphocyte Ratio and Clinical Outcomes in COPD: Recent Evidence and Future Perspectives. European Respiratory Review, 27, Article ID: 170113. https://doi.org/10.1183/16000617.0113-2017 |
| [53] | Ruta, V.M., Man, A.M., Alexescu, T.G., et al. (2020) Neutrophil-to-Lymphocyte Ratio and Systemic Immune-Inflammation Index-Biomarkers in Interstitial Lung Disease. Medicina (Kaunas), 56, Article No. 381. https://doi.org/10.3390/medicina56080381 |
